Tenaya Therapeutics, INC Form 4 insider transactions

Leone D. Patterson, Chief Financial and Business Officer of Tenaya Therapeutics, acquired 35,000 shares of common stock and 205,000 stock options on February 23, 2024, according to a Form 4 filing.

CEO Faraz Ali received 505,000 stock options and 85,000 restricted stock units in Tenaya Therapeutics, Inc.